Related Experiment Video
Updated: Jul 5, 2026

08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates
Sandra Story1, Sayantan Bhaduri2, Dev P Arya3
1NUBAD LLC, Greer, SC 29650, USA.
Bioorganic & Medicinal Chemistry Letters
|July 3, 2026
Summary
Researchers developed a solid-phase synthesis for lipid-aminoglycoside compounds with potent antifungal activity against Candida species. Long-chain lipids enhanced efficacy, offering a promising strategy for new antifungal drug development.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Research
Background:
- Lipid-linked aminosugars exhibit notable antimicrobial properties.
- Existing methods for synthesizing complex lipid-aminoglycoside conjugates can be inefficient.
- There is a need for novel antifungal agents to combat rising drug resistance.
Purpose of the Study:
- To develop a rapid solid-phase synthesis strategy for lipid-aminoglycoside compounds.
- To screen synthesized compounds for antifungal activity against clinical fungal pathogens.
- To investigate the structure-activity relationship, particularly the role of lipid chain length.
Main Methods:
- Solid-phase synthesis of lipid-aminoglycoside conjugates linked via amino acids.
- Screening of synthesized compound library against eight species of Candida.
- Determination of minimal inhibitory concentrations (MICs).
Main Results:
- Lipid-neomycin conjugates demonstrated broad-spectrum antifungal activity against Candida species.
- Minimal inhibitory concentrations (MICs) ranged from 1.56 to 3.13 μM.
- Conjugates with long-chain saturated lipids were significantly more potent than those with short-chain or unsaturated lipids.
Conclusions:
- The developed solid-phase strategy enables efficient synthesis of diverse lipid-aminoglycoside compounds.
- Long-chain saturated lipids are crucial for enhanced antifungal potency.
- This approach offers a versatile platform for developing novel antifungal therapeutics.

